Condition

Primary Immune Thrombocytopenia (ITP) clinical trials and research

• 10Clinical trials
• 18Countries

Newest Primary Immune Thrombocytopenia (ITP) clinical trials

All recruiting trials (10)

• High-dose dexamethasone plus orelabrutinib versus placebo for newly diagnosed adult ITP

  This trial tests whether adding orelabrutinib to high-dose dexamethasone helps adults newly diagnosed with primary ITP raise and maintain their platelet counts compared with placebo.

  Recruiting Phase 3 Shandong University · Jinan, Shandong · NCT07559331

• Ianalumab plus a thrombopoietin receptor agonist for adults with ITP or Evans syndrome

  This study will test whether adding ianalumab to a doctor's chosen TPO-RA is tolerable for adults with immune thrombocytopenia (and an exploratory group with Evans syndrome) who have had prior treatments and are on a stable TPO-RA dose.

  Recruiting at 23 sites Phase 2 Novartis · Chandler, Arizona and 22 other locations · NCT07421167

• Intravenous immunoglobulin (5%) treatment for primary immune thrombocytopenia

  This study tests whether 5% intravenous immunoglobulin given daily for five days safely raises platelet counts in adults (18–65) with chronic primary ITP and platelet counts below 30 × 10^9/L.

  Recruiting at 9 sites Phase 3 Grand Shuyang Life Sciences (Chengdu) Co., Ltd. · Ankara, Altındağ and 8 other locations · NCT07233213

• Romiplostim combined with glucocorticoids for treating newly diagnosed adult ITP

  This study is testing if a new treatment combining romiplostim and glucocorticoids can help adults newly diagnosed with immune thrombocytopenia feel better compared to just using glucocorticoids alone.

  Recruiting Phase 2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT06992128

• Testing STSA-1301 injection for treating immune thrombocytopenia

  This study is testing a new injection called STSA-1301 to see if it can safely help people with immune thrombocytopenia improve their platelet levels.

  Recruiting at 7 sites Phase 1/2 Jiangsu BioJeTay Biotechnology Co., Ltd. · Bengbu, Anhui and 6 other locations · NCT06929299

• Registry for patients with Primary Immune Thrombocytopenia in Spain

  This study is collecting information from patients with Primary Immune Thrombocytopenia in Spain to better understand the condition and improve how it's treated.

  Recruiting at 29 sites Fundación Española de Hematología y Hemoterapía · A Coruña, A Coruña and 35 other locations · NCT06919341

• Safety evaluation of CC312 in patients with autoimmune diseases

  This study is testing a new treatment called CC312 to see if it's safe and tolerable for adults with autoimmune diseases like lupus and rheumatoid arthritis.

  Recruiting Early Phase 1 CytoCares Inc · Tianjin, China · NCT06888960

• Assessing the effects of efgartigimod IV in adults with primary immune thrombocytopenia

  This study is testing whether a new treatment called efgartigimod IV can help adults with primary immune thrombocytopenia feel better and improve their platelet counts.

  Recruiting at 93 sites Phase 3 argenx · Phoenix, Arizona and 93 other locations · NCT06544499

• Combining Belimumab with Rituximab for Chronic Immune Thrombocytopenia

  This study is testing if a new combination of two medications can help adults with chronic immune thrombocytopenia raise their platelet counts after other treatments have stopped working.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Créteil · NCT05338190

• Eltrombopag with rituximab versus eltrombopag alone for adults with ITP

  This study tests whether adding a single rituximab infusion to daily eltrombopag helps adults with previously treated ITP who still have low platelets.

  Recruiting Phase 4 Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT04518475

Related topics

Quick answers

How many Primary Immune Thrombocytopenia (ITP) clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in China (6 trials), France (2 trials), Spain (2 trials), United States (2 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 2: 2, Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →